The biotech industry has pushed the boundaries of human health and scientific understanding for decades. But a new revolution is brewing—not in the lab, but in the supply chain. By embracing circularity, where resources are kept in use for as long as possible, the industry is poised for unparalleled innovation, and savvy investors are taking notice.